Published in BMC Pediatr on August 06, 2010
Prevalence and risk factors of undernutrition among antiretroviral-therapy-naïve subjects aged under 5 years old in Makurdi, Nigeria: a retrospective study. Int J Gen Med (2015) 1.38
Predictors of treatment failure and time to detection and switching in HIV-infected Ethiopian children receiving first line anti-retroviral therapy. BMC Infect Dis (2012) 1.17
Unresolved antiretroviral treatment management issues in HIV-infected children. J Acquir Immune Defic Syndr (2012) 1.17
Initiation of antiretroviral therapy before 6 months of age is associated with faster growth recovery in South African children perinatally infected with human immunodeficiency virus. J Pediatr (2013) 1.00
Severe malnutrition and metabolic complications of HIV-infected children in the antiretroviral era: clinical care and management in resource-limited settings. Am J Clin Nutr (2011) 0.99
Anaemia in HIV-infected children: severity, types and effect on response to HAART. BMC Pediatr (2012) 0.97
Incidence and risk factors for first line anti retroviral treatment failure among Ugandan children attending an urban HIV clinic. AIDS Res Ther (2013) 0.95
Optimal time for initiating antiretroviral therapy (ART) in HIV-infected, treatment-naive children aged 2 to 5 years old. Cochrane Database Syst Rev (2013) 0.94
Aetiology and management of malnutrition in HIV-positive children. Arch Dis Child (2014) 0.92
Predictors of mortality among children on Antiretroviral Therapy at a referral hospital, Northwest Ethiopia: a retrospective follow up study. BMC Pediatr (2012) 0.91
Poor clinical outcomes for HIV infected children on antiretroviral therapy in rural Mozambique: need for program quality improvement and community engagement. PLoS One (2014) 0.90
Factors Determining Survival and Retention among HIV-Infected Children and Adolescents in a Community Home-Based Care and a Facility-Based Family-Centred Approach in Kampala, Uganda: A Cohort Study. ISRN AIDS (2014) 0.88
Effect of Age at Antiretroviral Therapy Initiation on Catch-up Growth Within the First 24 Months Among HIV-infected Children in the IeDEA West African Pediatric Cohort. Pediatr Infect Dis J (2015) 0.88
Challenges in infant and young child nutrition in the context of HIV. AIDS (2013) 0.85
Weight as predictors of clinical progression and treatment failure: results from the TREAT Asia Pediatric HIV Observational Database. J Acquir Immune Defic Syndr (2014) 0.81
Immunological Response of Hiv-Infected Children to Highly Active Antiretoviral Therapy at Gondar University Hospital, North-Western Ethiopia. Ethiop J Health Sci (2016) 0.80
Safety and effectiveness of combination antiretroviral therapy during the first year of treatment in HIV-1 infected Rwandan children: a prospective study. PLoS One (2014) 0.79
Antiretroviral treatment in HIV-infected infants and young children: novel issues raised by the Mississippi baby. Expert Rev Anti Infect Ther (2014) 0.79
Factors associated with antiretroviral treatment interruption in human immunodeficiency virus (HIV)-1-infected children attending the Jos University Teaching Hospital, Jos, Nigeria. Niger Med J (2015) 0.79
Growth reconstitution following antiretroviral therapy and nutritional supplementation: systematic review and meta-analysis. AIDS (2015) 0.79
Antiretroviral treatment in HIV-1 infected pediatric patients: focus on efavirenz. Pediatric Health Med Ther (2014) 0.79
The long-term effectiveness of generic adult fixed-dose combination antiretroviral therapy for HIV-infected Ugandan children. Afr Health Sci (2012) 0.78
Factors Associated with the Development of Drug Resistance Mutations in HIV-1 Infected Children Failing Protease Inhibitor-Based Antiretroviral Therapy in South Africa. PLoS One (2015) 0.78
Cohort profile: improving treatment of HIV-infected Ethiopian children through better detection of treatment failure in southern Ethiopia. BMJ Open (2017) 0.75
[Impact of antiretroviral therapy on the biological profile of HIV positive children followed-up at Yaounde University Hospital in Cameroon]. Pan Afr Med J (2015) 0.75
Growth Recovery Among HIV-infected Children Randomized to Lopinavir/Ritonavir or NNRTI-based Antiretroviral Therapy. Pediatr Infect Dis J (2016) 0.75
Magnitude of cytopenias among HIV-infected children in Bahir Dar, northwest Ethiopia: a comparison of HAART-naïve and HAART-experienced children. HIV AIDS (Auckl) (2017) 0.75
Universal antiretroviral therapy for HIV-infected children: a review of the benefits and risks to consider during implementation. J Int AIDS Soc (2017) 0.75
Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA (2007) 7.00
Scaling up antiretroviral therapy in resource-limited settings: guidelines for a public health approach. Executive summary. April 2002. IAPAC Mon (2002) 6.33
Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Lancet Infect Dis (2008) 4.80
Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy. J Acquir Immune Defic Syndr (2007) 3.78
Dried blood spots improve access to HIV diagnosis and care for infants in low-resource settings. J Acquir Immune Defic Syndr (2005) 3.38
Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa. BMC Pediatr (2007) 2.67
Early response to highly active antiretroviral therapy in HIV-1-infected Kenyan children. J Acquir Immune Defic Syndr (2007) 2.34
Long-term survival and immuno-virological response of African HIV-1-infected children to highly active antiretroviral therapy regimens. AIDS (2006) 2.01
Growth failure in children with HIV infection. J Acquir Immune Defic Syndr (2000) 1.89
Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth. Pediatrics (2002) 1.82
HIV prevalence and mortality among children undergoing treatment for severe acute malnutrition in sub-Saharan Africa: a systematic review and meta-analysis. Trans R Soc Trop Med Hyg (2008) 1.81
Differences in factors associated with initial growth, CD4, and viral load responses to ART in HIV-infected children in Kampala, Uganda, and the United Kingdom/Ireland. J Acquir Immune Defic Syndr (2008) 1.75
Growth failure as a prognostic indicator of mortality in pediatric HIV infection. Pediatrics (1997) 1.70
Growth in HIV-infected children receiving antiretroviral therapy at a pediatric infectious diseases clinic in Uganda. AIDS Patient Care STDS (2008) 1.41
Growth of human immunodeficiency virus-infected children receiving highly active antiretroviral therapy. Pediatr Infect Dis J (2005) 1.35
Pattern and predictors of immunologic recovery in human immunodeficiency virus-infected children receiving non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy. Pediatr Infect Dis J (2009) 1.32
Impact on weight and height with the use of HAART in HIV-infected children. Pediatr Infect Dis J (2007) 1.30
Prevalence and risk factors associated with antiretroviral resistance in HIV-1-infected children. J Med Virol (2007) 1.13
Response to antiretroviral therapy in HIV-infected Ugandan children exposed and not exposed to single-dose nevirapine at birth. J Acquir Immune Defic Syndr (2009) 1.12
Nutritional aspects of HIV-infected children receiving highly active antiretroviral therapy. AIDS (2003) 1.12
Two-year clinical and immune outcomes in human immunodeficiency virus-infected children who reconstitute CD4 T cells without control of viral replication after combination antiretroviral therapy. Pediatrics (2004) 1.11
Immunologic and virologic responses to HAART in severely immunocompromised HIV-1-infected children. AIDS (1999) 1.11
Growth velocity, fat-free mass and energy intake are inversely related to viral load in HIV-infected children. J Nutr (2000) 1.01
Growth, survival and viral load in symptomatic childhood human immunodeficiency virus infection. Pediatr Infect Dis J (2003) 1.01
Impact of HAART on survival, weight gain and resting energy expenditure in HIV-1-infected children in India. Ann Trop Paediatr (2010) 1.00
The emergence and epidemiology of resistance in the nucleoside-experienced HIV-infected population. Antivir Ther (2001) 1.00
CD4 cell response before and after HAART initiation according to viral load and growth indicators in HIV-1-infected children in Abidjan, Côte d'Ivoire. J Acquir Immune Defic Syndr (2008) 0.98
Effectiveness of antiretroviral therapy in treating paediatric HIV/AIDS in Jamaica. West Indian Med J (2008) 0.83
Epidemiology of HIV and AIDS among adolescents and young adults in the United States. J Adolesc Health (2006) 2.97
Estimating the net effect of HIV on child mortality in African populations affected by generalized HIV epidemics. J Acquir Immune Defic Syndr (2005) 2.63
Intimate partner violence against women in eastern Uganda: implications for HIV prevention. BMC Public Health (2006) 2.26
Analysis of nevirapine resistance in HIV-infected infants who received extended nevirapine or nevirapine/zidovudine prophylaxis. AIDS (2011) 1.59
Early weaning of HIV-exposed uninfected infants and risk of serious gastroenteritis: Findings from two perinatal HIV prevention trials in Kampala, Uganda. J Acquir Immune Defic Syndr (2010) 1.50
Antenatal HIV testing in rural eastern Uganda in 2003: incomplete rollout of the prevention of mother-to-child transmission of HIV programme? BMC Int Health Hum Rights (2006) 1.35
Timeliness of childhood vaccinations in Kampala Uganda: a community-based cross-sectional study. PLoS One (2012) 1.35
Effectiveness of repeat single-dose nevirapine for prevention of mother-to-child transmission of HIV-1 in repeat pregnancies in Uganda. J Acquir Immune Defic Syndr (2007) 1.20
Tuberculosis treatment default among HIV-TB co-infected patients in urban Uganda. Trop Med Int Health (2011) 1.17
Noninferiority of a task-shifting HIV care and treatment model using peer counselors and nurses among Ugandan women initiated on ART: evidence from a randomized trial. J Acquir Immune Defic Syndr (2013) 1.16
Teacher ratings of mental health among school children in Kinshasa, Democratic Republic of Congo. Eur Child Adolesc Psychiatry (2005) 1.16
The good, the bad, and the unknown: quality of clinical laboratories in Kampala, Uganda. PLoS One (2013) 1.14
Response to antiretroviral therapy in HIV-infected Ugandan children exposed and not exposed to single-dose nevirapine at birth. J Acquir Immune Defic Syndr (2009) 1.12
Operational issues and barriers to implementation of prevention of mother-to-child transmission of HIV (PMTCT) interventions in Sub-Saharan Africa. Curr HIV Res (2013) 1.12
The impact of maternal highly active antiretroviral therapy and short-course combination antiretrovirals for prevention of mother-to-child transmission on early infant infection rates at the Mulago national referral hospital in Kampala, Uganda, January 2007 to May 2009. J Acquir Immune Defic Syndr (2011) 1.08
Neuropsychological effects of konzo: a neuromotor disease associated with poorly processed cassava. Pediatrics (2013) 1.06
CD4, viral load response, and adherence among antiretroviral-naive breast-feeding women receiving triple antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV in Kisumu, Kenya. J Acquir Immune Defic Syndr (2012) 1.05
Helicobacter pylori in apparently healthy children aged 0-12 years in urban Kampala, Uganda: a community-based cross sectional survey. BMC Gastroenterol (2010) 1.03
Pharmacokinetics and safety of tenofovir in HIV-infected women during labor and their infants during the first week of life. J Acquir Immune Defic Syndr (2014) 1.01
Use of a high resolution melting assay to analyze HIV diversity in HIV-infected Ugandan children. Pediatr Infect Dis J (2012) 0.99
Severe malnutrition and metabolic complications of HIV-infected children in the antiretroviral era: clinical care and management in resource-limited settings. Am J Clin Nutr (2011) 0.99
Prevalence and factors associated with traditional herbal medicine use among patients on highly active antiretroviral therapy in Uganda. BMC Public Health (2011) 0.99
In utero HIV infection is associated with an increased risk of nevirapine resistance in ugandan infants who were exposed to perinatal single dose nevirapine. AIDS Res Hum Retroviruses (2009) 0.98
Phase I/II trial of HIV-1 hyperimmune globulin for the prevention of HIV-1 vertical transmission in Uganda. AIDS (2002) 0.98
Considerations in using US-based laboratory toxicity tables to evaluate laboratory toxicities among healthy malawian and Ugandan infants. J Acquir Immune Defic Syndr (2010) 0.98
Intimate partner violence and infant morbidity: evidence of an association from a population-based study in eastern Uganda in 2003. BMC Pediatr (2007) 0.96
Faecal calprotectin concentrations in apparently healthy children aged 0-12 years in urban Kampala, Uganda: a community-based survey. BMC Pediatr (2011) 0.95
Effect of chloroquine on human immunodeficiency virus (HIV) vertical transmission. Afr Health Sci (2003) 0.95
The high burden of infant deaths in rural Burkina Faso: a prospective community-based cohort study. BMC Public Health (2012) 0.92
Addition of extended zidovudine to extended nevirapine prophylaxis reduces nevirapine resistance in infants who were HIV-infected in utero. AIDS (2010) 0.91
Malaria parasitaemia among infants and its association with breastfeeding peer counselling and vitamin A supplementation: a secondary analysis of a cluster randomized trial. PLoS One (2011) 0.91
Multivitamin supplementation in HIV infected adults initiating antiretroviral therapy in Uganda: the protocol for a randomized double blinded placebo controlled efficacy trial. BMC Infect Dis (2012) 0.90
Kinetics of nevirapine and its impact on HIV-1 RNA levels in maternal plasma and breast milk over time after perinatal single-dose nevirapine. J Acquir Immune Defic Syndr (2012) 0.89
Cost of individual peer counselling for the promotion of exclusive breastfeeding in Uganda. Cost Eff Resour Alloc (2011) 0.89
Association of recent HIV infection and in-utero HIV-1 transmission. AIDS (2011) 0.89
Clinical spectrum, risk factors and outcome of immune reconstitution inflammatory syndrome in patients with tuberculosis-HIV coinfection. Antivir Ther (2012) 0.88
Effects of improved access to transportation on emergency obstetric care outcomes in Uganda. Afr J Reprod Health (2014) 0.88
Nevirapine resistance in women and infants after first versus repeated use of single-dose nevirapine for prevention of HIV-1 vertical transmission. J Infect Dis (2008) 0.87
Analysis of drug resistance in children receiving antiretroviral therapy for treatment of HIV-1 infection in Uganda. AIDS Res Hum Retroviruses (2010) 0.87
Modelling the potential impact and cost of scaling-up male circumcision in resource poor settings: A case of Uganda. Afr J AIDS Res (2013) 0.86
Emergence and persistence of nevirapine resistance in breast milk after single-dose nevirapine administration. AIDS (2010) 0.84
Distribution of haematological and chemical pathology values among infants in Malawi and Uganda. Paediatr Int Child Health (2012) 0.81
Reduction of unnecessary transfusion and intravenous fluids in severely malnourished children is not enough to reduce mortality. Ann Trop Paediatr (2008) 0.80
Human papillomavirus prevalence and cytopathology correlation in young Ugandan women using a low-cost liquid-based Pap preparation. Diagn Cytopathol (2010) 0.80
Prevalence of Helicobacter pylori in HIV-infected, HAART-naïve Ugandan children: a hospital-based survey. J Int AIDS Soc (2011) 0.79
Total lymphocyte count: not a surrogate marker for risk of death in HIV-infected Ugandan children. J Acquir Immune Defic Syndr (2008) 0.79
University students and the risk of HIV and other sexually transmitted infections in Uganda: the Crane survey. Int J Adolesc Med Health (2014) 0.78
Analysis of HIV tropism in Ugandan infants. Curr HIV Res (2010) 0.78
Infant feeding survival and Markov transition probabilities among children under age 6 months in Uganda. Am J Epidemiol (2013) 0.78
Long-term clinical and immunologic outcomes of HIV-infected women with and without previous exposure to nevirapine. Trop Med Int Health (2013) 0.78
Depressive and Anxiety Symptoms Predict Sustained Quality of Life Deficits in HIV-Positive Ugandan Adults Despite Antiretroviral Therapy: A Prospective Cohort Study. Medicine (Baltimore) (2016) 0.77
Multiple micronutrient supplementation does not reduce diarrhoea morbidity in Ugandan HIV-infected children: a randomised controlled trial. Paediatr Int Child Health (2012) 0.77
Comment on: the seroprevalence of Helicobacter pylori and its relationship to malaria in Ugandan children. Trans R Soc Trop Med Hyg (2012) 0.75
Multicountry Validation of SAMBA - A Novel Molecular Point-of-Care Test for HIV-1 Detection in Resource-Limited Setting. J Acquir Immune Defic Syndr (2017) 0.75
A look at ethics and AIDS -- We're trying to help our sickest people, not exploit them In the researcher's code of conduct, contradictions abound. Washington Post (1997) 0.75